Martin Sullivan, M.D., has been appointed executive medical director of Cardiovascular Medicine at INC Research. Dr. Sullivan will leverage his therapeutic expertise with cardiovascular drugs and devices to provide hands-on medical management of the company’s cardiology trials and to drive clinical development globally in this therapeutic area.
 
Dr. Sullivan brings more than 25 years of experience in medical practice and clinical research. Prior to joining the company, he worked as a research consultant specializing in noninvasive cardiology. Dr. Sullivan has had distinguished career at a variety of institutions including serving as associate professor of Medicine at Duke University, director of the Duke Center for Integrative Medicine, director of Cardiovascular Research at the Heartland Regional Medical Center in St. Joseph’s, MO, and a senior research consultant in the division of Cardiology at the University of North Carolina. Dr. Sullivan was also named an Established Investigator of the American Heart Association.
 
“The prevalence of cardiovascular diseases provides significant opportunity for the development of new therapies to improve the health and overall wellbeing of many patients worldwide,” said Sally Osmond, executive vice president and general manager, Cardiovascular and Endocrinology Clinical Development at INC Research. “Marty is a highly respected cardiologist with extensive experience both in practice and in clinical development, having implemented more than 100 clinical research projects. We’re thrilled to have a thought leader of his caliber to lead development of these complex trials.”